CT引导下经皮无水酒精加碘油注射治疗肝癌及转移瘤化疗栓塞后残存活灶

To analysis the effectiveness of percutaneous ethanol-lipiodol injiection by CT-guided after tansarterial chemoembolization(TACE) for hepatocellular carcinoma(HCC)

目的评价CT引导下经皮碘化油/无水酒精瘤体多点注射治疗肝癌(PEI/PII)的临床价值。方法15例肝癌TACE后两周,对残存肿瘤行PEI,4周后增强CT/MRI评价术后疗效。结果15例20个残存活灶,12例15个病灶直径≤3cm,12个病灶完全坏死,3个病灶坏死大于75%;2例3个病灶5cm≥病灶直径>3cm者,2个坏死范围≥75%,1个坏死范围≥50%,1例病灶直径>5cm,病灶坏死范围<50%。结论TACE结合PEI/PII治疗肝癌,对于小于3cm的病灶,能更好提高疗效,有较高的临床治疗价值。

Objective To evaluate the value of percutaneous Ethanol -Lipiodol injiection by CT- guided after TACE . Methods TACE following two weeks, 17 patients with HCC were treated by PEI/PII, iodized oil retention was estimated with CT/MRI performed 4 weeks after treatment. Results Fifteen patients have 20 remnants, 12 of 15 remnants less than 3 cm were complete necrosis, 3 were 75% or greater ; 2 of 3 remnants between 3 - 5 cm were 75% or greater of necrosis , 1 was 50% or greater ; the diameter of 1 remnant exceeded 5 cm , necrosis was less than 50%. Conclusions TACE of HCC with PEI/PII is an effective method and greater value, espcialy for less than 3 em.